Exome sequencing of ASD cohorts identified several ASD gene candidates with de novo loss-of-function mutations or de novo missense variants such as FMR1, TSC1/2, and SYNGAP1 [36], which, when mutated in rodent models, culminated in epilepsy and ASD [37]. This evidence concerns the gene FMR1 and epilepsy.